Abraxis Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABRAXIS PHARM
ABRAXIS PHARM has one hundred and thirteen approved drugs.
Drugs and US Patents for Abraxis Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | VINCRISTINE SULFATE | vincristine sulfate | INJECTABLE;INJECTION | 070411-001 | Sep 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | ERYTHROMYCIN LACTOBIONATE | erythromycin lactobionate | INJECTABLE;INJECTION | 062604-002 | Nov 24, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | CALCIUM GLUCEPTATE | calcium gluceptate | INJECTABLE;INJECTION | 089373-001 | Apr 30, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

